# An Observational Study on the Progression of Clinically Isolated Syndrome to Multiple Sclerosis Over a 2-year Period

> **NCT01112657** · — · COMPLETED · sponsor: **Merck KGaA, Darmstadt, Germany** · enrollment: 154 (actual)

## Conditions studied

- Multiple Sclerosis

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01112657
- **Lead sponsor:** Merck KGaA, Darmstadt, Germany
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2008-11
- **Primary completion:** 2014-10
- **Final completion:** 2014-10
- **Target enrollment:** 154 (ACTUAL)
- **Last updated:** 2014-11-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01112657

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01112657, "An Observational Study on the Progression of Clinically Isolated Syndrome to Multiple Sclerosis Over a 2-year Period". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01112657. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*